Subscribe By E-Mail

Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement – Daily Markets (press release)

Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement
Daily Markets (press release)
24, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (SVA), a leading provider of vaccines in China, today announced that it received a letter dated January 18, 2012 from The Nasdaq Stock Market. Based on the departure of Ms. Chup Hung Mok from the

and more »

nasdaq – Google News